New Brunswick Scientific Selects Oracle as ERP Supplier to Align Global Operations Under Unified Platform for Growth
05 Janvier 2006 - 1:51PM
PR Newswire (US)
Standardization Enhances Operational Efficiencies and Economies of
Scale EDISON, N.J., Jan. 5 /PRNewswire-FirstCall/ -- New Brunswick
Scientific Co., Inc. (NBS) (NASDAQ:NBSC), a leading provider of a
comprehensive line of research equipment and scientific
instrumentation for use in the life science industry, today
announced the selection of the Oracle(R) E-Business Suite to align
its worldwide operations -- including sales, marketing, finance,
design, manufacturing, logistics and distribution -- under a
unified enterprise information system. "NBS' senior management and
Board of Directors determined that a global enterprise resource
planning (ERP) solution was needed to enhance efficiencies and
support future growth," said Vice President of Manufacturing
Operations John Powers. "Oracle clearly demonstrated its
understanding of our current mission critical requirements as well
as our need for future scalability in our IT capabilities." He
explained, "Previously, NBS ran with a series of disparate
information systems -- in part as a result of recent acquisitions,
but also as its legacy systems lacked sufficient scale and breadth
for current information needs. Faced with Sarbanes Oxley Section
404 compliance, our aggressive new-product development schedule and
the need for broadened front-end CRM and back-end financial tools,
we believe that Oracle's vertical position in the life science
sector and seamless workflows will provide us a strong
infrastructure on which to build. We were impressed by Oracle's
seamless technology stack, comprehensive application suite and
extensive offering of adjunct modules, which we view as
optimization tools for our current and future application
requirements. This initiative further enhances our use of
information technology to achieve economies of scale and increased
operational efficiencies, benefiting our consolidated operations in
terms of further improvements in productivity and customer
integration." The Company's comprehensive plan for a sequential
rollout across its global platform begins with U.S. operations in
2006, followed by all European and Asian operations in 2007. To be
added to New Brunswick Scientific's e-mail distribution list,
please click on the link below:
http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html
About New Brunswick Scientific New Brunswick Scientific Co., Inc.,
is a leading global provider of a comprehensive line of research
equipment and scientific instrumentation for use in the life
science industry. The Company's products are used in the creation,
maintenance and control of physical and biochemical environments
required for the growth, detection and storage of microorganisms
for medical, biological and chemical applications, as well as
environmental research and commercial product development. NBS is a
forerunner in the research and development of pioneering equipment
to meet the challenges of new areas of advancement in life science.
Established in 1946, New Brunswick Scientific is headquartered in
Edison, New Jersey, with sales and distribution facilities
strategically located in the United States, Europe and Asia. For
more information, please visit http://www.nbsc.com/ . This press
release contains "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-
looking statements may be identified by words such as "expects,"
"anticipates," "intends," "plans," "believes," "seeks,"
"estimates," "will" or words of similar meaning and include, but
are not limited to, statements about the expected future business
and financial performance of the Company. The forward-looking
statements involve a number of risks and uncertainties, including
but not limited to: changes in economic conditions, demand for the
Company's products, pricing pressures, intense competition in the
industries in which the Company operates, the need for the Company
to keep pace with technological developments and respond in a
timely manner to changes in customer needs, the Company's
dependence on third-party suppliers, the effect on foreign sales of
currency fluctuations, acceptance of new products, the labor
relations of the Company and its customers and other factors
identified in the Company's Securities and Exchange Commission
filings. Forward-looking statements are based on management's
current expectations and assumptions, which are inherently subject
to uncertainties, risks and changes in circumstances that are
difficult to predict. Actual outcomes and results may differ
materially from these expectations and assumptions due to changes
in global political, economic, business, competitive, market,
regulatory and other factors. The Company undertakes no obligation
to publicly update or review any forward-looking information,
whether as a result of new information, future developments or
otherwise. Oracle, JD Edwards, and PeopleSoft are registered
trademarks of Oracle Corporation and/or its affiliates. DATASOURCE:
New Brunswick Scientific Co., Inc. CONTACT: John Powers, V.P.,
Manufacturing Operations of New Brunswick Scientific Co., Inc.,
+1-732.650.2006, ; or Matthew J. Dennis, CFA, NBS Investor
Relations of Clear Perspective Group, LLC, +1-440-353-0552, Web
site: http://www.nbsc.com/
Copyright
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024